Flagship's Empress lays off 53% of staffers in push to get science to clinic.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/18/2025, pN.PAG-N.PAG. 1p.

Arch-backed HC Bioscience closes doors after seeing early data for tRNA asset.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/18/2025, pN.PAG-N.PAG. 1p.

Director of NIH's National Human Genome Research Institute departs: Stat.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/18/2025, pN.PAG-N.PAG. 1p.

Orca's cell therapy trounces traditional care in blood cancer phase 3, swimming into space's 'holy grail'.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/17/2025, pN.PAG-N.PAG. 1p.

Curevo rounds up $110M to challenge GSK's Shringrix, nabs Moncef Slaoui to lead board.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/17/2025, pN.PAG-N.PAG. 1p.

Fierce Biotech Layoff Tracker 2025: Sutro halves staff; GRObio restructures.

Authors: Masson, Gabrielle (AUTHOR), Incorvaia, Darren (AUTHOR)

Source: FierceBiotech. 3/14/2025, pN.PAG-N.PAG. 1p.

'I don't feel we lost momentum': Takeda's oncology execs sharpen focus after restructuring.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/13/2025, pN.PAG-N.PAG. 1p.

Manufacturer fuels Swiss biotech's next-gen vaccine portfolio in new investment deal.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/12/2025, pN.PAG-N.PAG. 1p.

J&J opts out of licensing Genmab's Darzalex challenger after look at phase 1/2 data.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/10/2025, pN.PAG-N.PAG. 1p.

Fierce Biotech Fundraising Tracker '25: Lila launches with $200M; Garuda grabs $50M series A.

Authors: Masson, Gabrielle (AUTHOR), Incorvaia, Darren (AUTHOR)

Source: FierceBiotech. 3/10/2025, pN.PAG-N.PAG. 1p.

Arrowhead finds RNAi kidney disease candidate is well tolerated in phase 1/2 IgAN trial cohort.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/10/2025, pN.PAG-N.PAG. 1p.

Nasdaq stock market plans move to 24-hour trading in US.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

NIH still terminating research grants, defying federal orders: Boston Globe.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs; Atea reduces head count by 25%.

Authors: Masson, Gabrielle (AUTHOR), Incorvaia, Darren (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

A look at biotech's biggest money raisers of 2024.

Authors: Park, Andrea (AUTHOR), Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

UPDATE: DOGE quietly decreases savings estimate for 30 terminated FDA leases.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/6/2025, pN.PAG-N.PAG. 1p.

Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/5/2025, pN.PAG-N.PAG. 1p.

Subject Terms: Sleep apnea syndromes, Weight loss, Cardiovascular diseases, Heart failure, Kidney diseases

US judge blocks Trump administration from cutting NIH grants amid ongoing litigation.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/5/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Actions & defenses (Law), Federal judges, Presidential administrations, Medical research, University research

Company/Entity: National Institutes of Health (U.S.)

People: Trump, Donald, 1946-

Trump NIH nominee Jayanta Bhattacharya says he doesn't plan on cutting more jobs in Senate hearing.

Authors: Masson, Gabrielle (AUTHOR)

Source: FierceBiotech. 3/5/2025, pN.PAG-N.PAG. 1p.

Subject Terms: Congressional hearings (U.S.), Sharing

Company/Entity: United States. Dept. of Health & Human Services , National Institutes of Health (U.S.)

People: Trump, Donald, 1946-

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs; ALX trims team.

Authors: Masson, Gabrielle (AUTHOR), Incorvaia, Darren (AUTHOR)

Source: FierceBiotech. 3/5/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Layoffs, Teams